HOME >> BIOLOGY >> NEWS
Common cold virus can cause polio in mice when injected into muscles

DURHAM, N.C. -- Virologists at Duke University Medical Center have discovered that, under the right conditions, a common cold virus closely related to poliovirus can cause polio in mice.

The researchers injected a cold virus called Coxsackievirus A21 into mice that were engineered to be susceptible to this particular virus. However, instead of developing a cold, the mice unexpectedly displayed paralytic symptoms characteristic of polio. The researchers determined that administering the virus directly into muscles, instead of the virus's normal home in the nasal cavity, was critical for development of polio.

The findings challenge traditional views as to what defines a poliovirus, said Matthias Gromeier, M.D., a Duke virologist and senior author of the study.

"In principle, Coxsackieviruses could cause polio in humans," said Gromeier. "We are in the process of eradicating polio worldwide, but if we eliminate the poliovirus and cease polio vaccinations, our immune systems wouldn't produce antibodies against polio, and Coxsackievirus could theoretically fill the niche of eradicated polio" he said.

Results of the study will be published in the Sept. 6, 2004, issue of the Proceedings of the National Academy of Sciences.

Until now, it has been widely accepted that Coxsackievirus and poliovirus cause distinct illnesses because they bind to different docking sites, called receptors, on host cell surfaces. The current study turned that belief on its head, said Gromeier. Poliomyelitis has long been regarded as the signature of poliovirus, a virus that recognizes and binds to the CD155 receptor. However, the mice were genetically engineered to have only the Coxsackie A21 receptor, called ICAM-1, and they did not have the poliovirus receptor. Still, when the mice were injected with Coxsackievirus, it initiated infection through the ICAM-1 receptor, and caused symptoms of polio.

The manner in which the mice were infected with Coxsa
'"/>

Contact: Becky Levine
Levin005@mc.duke.edu
919-684-4148
Duke University Medical Center
6-Sep-2004


Page: 1 2 3

Related biology news :

1. Common call for action on European Research Council (ERC)
2. Common therapy for HIV associated with cervical abnormality regression
3. Common chemicals morphing into potential toxins in Arctic
4. Common worm provides insights into salmonella virulence
5. Common virus may contribute to uncommon bone disease in children
6. Common airborne substance makes asthmatics more sensitive to house dust mites: study
7. Common genetic damages in non-dividing cells lead to the creation of mutant proteins
8. Common nutrients fed to pregnant mice altered their offsprings coat color
9. Common treatment for depression is safe and effective for Alzheimers patients
10. Common gene variant increases risk of atherosclerosis
11. Common thyroid cancer gene mutation found

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/4/2019)... ... 04, 2019 , ... Molecular Devices, a global leader in ... new President of Molecular Devices, replacing Greg Milosevich who has been appointed President ... Since joining Molecular Devices in a scientific engineering role, Ms. Murphy has held ...
(Date:6/1/2019)... ... May 31, 2019 , ... The ... Rosati recently invested in BioFactura’s $6M Series B Financing Round. , “With ... institutional investors who bring significant financial and business resources to bear as we ...
(Date:5/31/2019)... ... May 31, 2019 , ... The OilComm Conference ... TX, announced today that Ben Reiter, Senior Writer at Sports Illustrated and Author ... 3rd.     , Reiter predicted the Houston Astros would win the MLB championship in ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... (PRWEB) , ... June 11, 2019 , ... ... of Personalized Stem Cells Inc. (PSC) , has announced that their GMP ... Health, Food and Drug Branch for manufacturing. This is an important milestone ...
(Date:6/6/2019)... ... June 05, 2019 , ... WCCT Global, Inc ., a full-service ... today that they will be receiving 3 awards at the 2019 CRO Leadership Awards, ... awards in the categories of overall Quality and Compatibility (Access to desired markets, cultural ...
(Date:5/31/2019)... Redwood City, California (PRWEB) , ... ... ... received allowance of our patent applications from the USPTO providing proprietary interest ... SYSTEM AND METHOD FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP ...
(Date:5/31/2019)... NEWPORT BEACH, Calif. (PRWEB) , ... May 30, ... ... the future of neurotoxins, is pleased to announce the strategic acquisition of Metabiologics, ... for research. The acquisition provides Object exclusive ownership and commercialization rights to a ...
Breaking Biology Technology:
Cached News: